AZ Form 308-P Guide
Form 308-P: Executive Summary
Arizona Form 308-P computes the credit for qualified research activities conducted within the state, offering a tiered credit rate of 24% for initial expenditures and 15% for amounts exceeding $2.5 million.
Contextual Analysis
The Arizona Research and Development (R&D) Tax Credit is a non-refundable credit (with specific refundability exceptions for small businesses) designed to incentivize technical innovation within the state. Form 308-P is the specific filing instrument used by partnerships and S-corps to calculate this credit before passing it through to partners or shareholders.
Unlike the federal credit which often relies on complex "base amount" calculations from the 1980s, Arizona provides a more streamlined approach based on Qualified Research Expenses (QREs) excess over a base amount. The distinction of the Arizona credit is its generosity towards smaller to mid-sized R&D operations via the tiered rate structure.
Key Statutory Statistics
-
✓
24% Credit Rate: Applied to the first $2.5 million of excess QREs.
-
✓
15% Credit Rate: Applied to any excess QREs above $2.5 million.
-
✓
15 Year Carryforward: Unused credits can be carried forward for 15 consecutive taxable years.
Eligible Expense Composition
Typical distribution of QREs in Tech/Manufacturing sectors.
Why Form 308-P Matters
For Arizona businesses, this form is the gateway to monetizing innovation. Failing to file 308-P accurately results in the forfeiture of credits that dollar-for-dollar reduce state income tax liability.
Interactive Credit Calculator
Simulate the Form 308-P calculation logic. Adjust the input values to see how the tiered rates (24% vs 15%) affect the total estimated credit.
1. Enter 2024 QREs
Simplified for demo purposes.
Total Estimated AZ Credit
$0.00
Tier 1 Contribution (24%)
$0.00
Tier 2 Contribution (15%)
$0.00
Credit Composition Analysis
Revenue Office Guidance & Law
Breakdown of Arizona Revised Statutes (A.R.S.) and Department of Revenue rulings.
This statute establishes the credit for research and development expenses. It explicitly adopts the federal definition of "Qualified Research" found in Section 41 of the Internal Revenue Code (IRC), with specific modifications for the state.
Normally, tax credits are non-refundable (they can only reduce tax to $0). However, this statute allows "Qualified Small Businesses" to receive a refund of 75% of the excess credit instead of carrying it forward.
- Must have less than 150 full-time equivalent employees globally.
- The refund is capped (subject to ACA maximums allocated by the Arizona Commerce Authority).
- Requires a Certificate of Qualification from the ACA *before* filing Form 308-P.
The Arizona Department of Revenue (ADOR) strictly enforces substantiation. Taxpayers must retain:
Wages
Time tracking logs, project lists, and W-2s linking hours to specific R&D projects.
Contracts
Agreements showing who retains rights and bears the economic risk of the research.
Case Study: BioTech AZ Solutions
A practical application of Form 308-P for a growing Phoenix-based firm.
The Scenario
BioTech AZ Solutions is an S-Corp developing new irrigation sensor technology. In 2024, they spent heavily on engineering wages and prototyping supplies. They have 45 employees.
The Calculation Steps
- Determine Excess: $3.2M (QRE) - $1.0M (Base) = $2,200,000 Excess.
- Apply Tier 1: Since the excess ($2.2M) is under the $2.5M threshold, the entire amount is taxed at 24%.
- Calculation: $2,200,000 × 24% = $528,000 Credit.
Strategic Decision: Refund vs Carryforward
Since BioTech AZ has < 150 employees, they qualify for the refund option.
The chart above illustrates the trade-off. Taking the 75% refund ($396k) provides immediate liquidity, whereas carrying forward preserves the full value ($528k) but delays realization.
Conclusion
For companies like BioTech AZ, Form 308-P is not just compliance—it is a significant source of non-dilutive capital.
The 24% rate on the first $2.5M of excess makes Arizona one of the most competitive states for early-stage R&D.
Arizona R&D Tax Credit Compliance: A Deep Dive into Partnership Distribution Mechanics (Form 308-P)
Form 308-P is the mandatory Arizona tax schedule used by partnerships to allocate the state’s Credit for Increased Research Activities (R&D credit) proportionally to its individual and corporate partners. This form is essential for ensuring accurate flow-through of both non-refundable tax offsets and the potentially available refundable credit portion.1
This schedule, officially titled “Credit for Increased Research Activities – Distribution to Partners of a Partnership,” serves as the official mechanism for a pass-through entity to transfer the R&D tax benefit calculated on the entity’s own Form 308 to its constituent owners.1 Partnerships that successfully generate the Credit for Increased Research Activities in a given taxable year are required by the Arizona Department of Revenue (ADOR) to complete Form 308-P for each partner. This step ensures that the partners—whether they are individuals, C corporations, or other entities—receive the legally mandated documentation required to substantiate the credit claim on their respective Arizona income tax returns.2 Form 308-P thus functions identically to a federal K-1 schedule, but is specific to the Arizona R&D credit, acting purely as an allocation and reporting instrument rather than a calculation tool.
Statutory Foundation and Program Mechanics (A.R.S. §43-1168)
A. Purpose and Eligibility of the Arizona R&D Tax Credit
The Arizona Research and Development (R&D) Tax Credit program was established under A.R.S. §41-1507 with the explicit goal of encouraging Arizona businesses to continue investing in research and development activities within the state.4 The program provides a state income tax credit for increased research and development activities.
A critical requirement of the Arizona R&D tax credit is the geographic restriction: qualified research must be conducted exclusively within the state of Arizona.6 This includes research conducted at an Arizona state university, provided it is funded by the taxpayer.4 The scope of qualified research mirrors the federal definition under Internal Revenue Code (IRC) Section 41, referring to research undertaken to discover technological information intended for use in developing a new or improved business component, and which involves a process of experimentation.7
The statute specifically accommodates flow-through structures. If two or more taxpayers, including corporate partners within a partnership, share in the eligible Qualified Research Expenses (QREs), each taxpayer is eligible to receive a proportionate share of the final tax credit.6 This allowance is the foundational premise necessitating the creation and distribution of Form 308-P.
B. The Dual Credit System: Administration and Compliance Prerequisites
The Arizona R&D credit system is bifurcated, consisting of both non-refundable and refundable components, each administered by a separate state agency, which adds complexity to compliance.8
The non-refundable component is administered by the Arizona Department of Revenue (ADOR). This portion of the credit can only be used to offset the taxpayer’s Arizona income tax liability and does not result in a cash refund.8
The refundable component, however, is administered by the Arizona Commerce Authority (ACA). Accessing any cash refund requires rigorous pre-approval and certification.4 A critical compliance prerequisite for any partnership seeking to pass through a refundable credit to its partners is securing a Certificate of Qualification from the ACA prior to filing its tax return with the ADOR.4 The partnership must confirm this certificate has been received directly on Form 308-P before proceeding with the distribution of the refundable amount.10 This structure places a significant administrative burden on the partnership to initiate and complete the ACA approval process well in advance of the tax filing deadline.
C. Statutory Limitations and Credit Duration
The state imposes statutory limitations on both the aggregate value and the carryforward period of the R&D credits.
The Refundable Cap is subject to an annual limit. Recent legislative changes have increased the aggregate annual cap on the refundable portion of the R&D credit from $5 million to $10 million.11 The ADOR confirmation states that this $10 million limit applies to the combined individual and corporate income tax credits approved across the entire calendar year.12 Because demand for the refundable credit frequently exceeds the allotted pool—as illustrated by the $6,759,095 requested in 2022 against a prior $5 million cap 13—the need for early, proactive ACA certification by the partnership is crucial to secure access to these funds.
Furthermore, the duration for which an unused, non-refundable credit may be carried forward depends on the date the credit was first established.2 For businesses advising their partners on long-term tax modeling, these dates are highly relevant:
Table: Arizona R&D Credit Carryforward Rules
| Credit Established | Statutory Carryforward Period | Applicable Guidance |
| Before January 1, 2022 | Fifteen (15) Consecutive Taxable Years | ADOR Form 308 Instructions 2 |
| From and After December 31, 2021 | Ten (10) Consecutive Taxable Years | ADOR Form 308 Instructions 2 |
The reduction in the carryforward period from 15 years to 10 years for credits established after 2021 introduces a critical element of strategic tax planning for partnerships. This shortened utilization window means that partners must assess their projected Arizona taxable income more critically. Where a partner anticipates volatile or limited near-term tax liability, the overall long-term value of the non-refundable credit decreases. Consequently, the eligibility for the ACA refundable option becomes substantially more valuable for cash flow management, emphasizing the need for the partnership to aggressively pursue the ACA certification.2
Calculating the Partnership Credit: Context from Form 308
Form 308-P is entirely dependent on the partnership’s successful and verifiable calculation of the Qualified Research Expenses (QREs) and the resulting credit amount on the preceding document, Form 308 (Credit for Increased Research Activities).
A. Methods for Credit Determination
The Arizona R&D credit calculation is fundamentally based on “excess research expenditures”—that is, QREs incurred above a statutory base amount.7 Taxpayers have two options for calculating this base amount: the Regular (Incremental) Credit method or the Alternative Simplified Credit (ASC) method.14
While these calculations closely follow the framework established in the federal IRC $\S 41$, they must use only Arizona-sourced QREs and Arizona gross receipts.14 Key parameters of the calculation, such as the fixed-base percentage calculation, generally follow federal rules, with caps specified in Arizona law. For instance, the fixed-base percentage cannot exceed 16%.15 The resulting base amount must not be less than 50% of the current year’s QREs.16
B. Tiered Rate Application (A.R.S. §43-1168)
Arizona employs a highly incentivized, tiered rate structure applied to the calculated excess QREs, which is a major factor driving the value distributed through Form 308-P:
Table: Arizona R&D Tax Credit Calculation Tiers
| Excess QRE Threshold | Credit Rate (Until 12/31/2030) | Post-2030 Credit Rate |
| First $2.5 Million | 24% | 20% |
| Excess over $2.5 Million | 15% | 11% |
The analysis of the tiered structure reveals a significant policy urgency for R&D partnerships. The statutory rate step-down scheduled after December 31, 2030, which reduces the rate on the first $\$2.5$ million from 24% to 20% (a four-percentage point drop) and the excess rate from 15% to 11% 9, is substantial. This legislative structure provides a clear, time-limited incentive. Partnerships must strategically maximize qualifying activities and ensure compliance now to capture these materially higher rates, a crucial consideration for long-term capital forecasting.
C. Compliance Dependency and Audit Risk
The final total calculated credit amount is summarized on Form 308, Part 4, Line 29.17 This number, along with the maximum authorized refundable amount (Form 308, Part 5, Line 35), forms the sole basis for the distribution entered on Form 308-P.10
The fundamental compliance risk for all partners receiving distributions via Form 308-P is centralized at the partnership level. Since the state calculation relies heavily on federal IRC §41 definitions, the partnership must adhere rigorously to federal standards, including the Four-Part Test.18 Common mistakes, such as inadequate time tracking, lack of detailed technical narratives, misclassifying routine development, or errors in contractor expense calculations (the 65% rule violation), can invalidate the underlying QREs.18 A successful ADOR audit of the partnership’s Form 308, which reduces the total credit, simultaneously nullifies or reduces the credit distributed to all partners via Form 308-P. This centralized failure exposes all partners to cascading adjustments, necessitating amended state returns and potential penalties.
Form 308-P: Distribution to Partners of a Partnership
Form 308-P acts as the communication link, detailing the proportionate allocation of the credit generated by the partnership to each specific partner.
A. General Partner Information (Part 1)
Part 1 requires the identifying information of the partnership, including its name and Employer Identification Number (EIN).3 Crucially, the form then requires the identification of the specific partner receiving the credit, including the partner’s name, EIN or Social Security Number (SSN), and the partner’s precise proportionate share of the credit.3 This proportionate share must be consistent with the underlying partnership agreement and other income allocation schedules (such as the federal K-1).
B. Part 2: Distribution of the Total Credit Passed Through (Non-Refundable)
This section allocates the entire calculated credit (both refundable and non-refundable components) to the partner, establishing the total amount the partner is eligible to claim.
- Line 3: The partnership enters the total amount of the credit for increased research activities, which is derived directly from Form 308, Part 4, Line 29.3
- Line 4: This line determines the partner’s proportionate share of the credit. The amount on Line 3 is multiplied by the partner’s proportionate share percentage reported on Line 2(c). The result on Line 4 is the maximum total credit the partner can claim against their Arizona tax liability.3
C. Part 3: Distribution of the Maximum Refundable Portion
Part 3 is dedicated solely to passing through the maximum portion of the credit that has been certified by the ACA for refundability.10
The process begins with a crucial compliance check: the partnership must confirm if it has received the required Certificate from the Arizona Commerce Authority.10 If the answer is “No,” the instructions mandate that the partnership must stop the process for the refundable portion, demonstrating the administrative separation required between the two credit streams.10 This segregation is necessary to isolate the highly regulated, capped refundable credit from the standard non-refundable carryover.
- Line 5: If certified, the partnership enters the maximum refund amount authorized by the ACA, derived from Form 308, Part 5, Line 35.10
- Line 6: The partner’s specific share of this maximum refundable amount is then calculated based on the proportionate share percentage.
D. Partner Reporting Requirements
The completed Form 308-P serves as the substantiating evidence for the partner’s claim. The reporting mechanism depends on the type of partner 10:
- Individual Partners: Enter the allocated amounts on Arizona Form 308-I, Credit for Increased Research Activities – Individuals, and ultimately utilize the credit on Arizona Form 301, Nonrefundable Individual Tax Credits and Recapture.2
- Corporate or Other Partners: Enter the allocated credit amounts on their own Arizona Form 308, and subsequently utilize the credit on Arizona Form 300, Nonrefundable Corporate Tax Credits and Recapture.2
A key technical requirement involves coordination between the partnership’s and the partner’s tax years. If the partner files on a calendar year basis but the partnership files on a fiscal year basis, the partner is required to claim the credit on their tax return for the year in which the entity’s fiscal year ends.10 This timing requirement demands meticulous coordination between partners and partnership accountants to ensure the credit is claimed in the correct tax period, preventing common filing errors.
ADOR and ACA Compliance Guidance for Pass-Through Entities
The flow-through nature of the credit imposes distinct filing and administrative requirements on both the partnership and its partners.
A. ADOR Guidance on Flow-Through Documentation
The partnership must complete Form 308 to calculate the credit and then prepare Form 308-P for each partner (excluding certain trust or estate partners).2 The partnership is mandated to furnish each partner with a completed copy of their Form 308-P. When the partnership files its tax return, it must include its primary Form 308 and one copy of each completed Form 308-P.2
Individual partners claiming the credit must retain their received Form 308-P. If a taxpayer is claiming a pass-through credit from multiple partnerships, they must include copies of all Forms 308-P received with their tax return.20
B. ACA Certification Process Criticality
The highly beneficial refundable component of the Arizona R&D credit is subject to strict eligibility criteria and a competitive application process administered by the ACA.4 The maximum refund is capped annually, meaning that early application for the Certificate of Qualification is essential to overcome the possibility that demand exceeds the available funding pool.12 The absolute necessity of securing the ACA certificate is administratively reinforced by the “STOP” command built into Form 308-P instructions for Part 3.10
The centralized nature of the R&D calculation on Form 308 means the partnership structure focuses the potential audit risk on the entity. Should the underlying calculation fail an ADOR audit due to insufficient documentation (e.g., poor time tracking, lack of technical support, or misapplication of the 65% contractor rule), the flow-through credit distributed to all partners via Form 308-P is simultaneously invalidated or reduced.18 Therefore, robust, contemporaneous documentation systems must be implemented and maintained at the partnership level to secure the tax benefit for all partners.
Table: Form 308-P Distribution Flow Summary
| Step | Partnership Action (Form 308/308-P) | Partner Action (Receiving 308-P) |
| 1. Calculation | Partnership calculates total R&D credit (Form 308, Line 29). | N/A |
| 2. Refund Certification | Partnership applies for and secures ACA certificate (if seeking refundability). | N/A |
| 3. Distribution | Partnership completes Form 308-P for each partner, noting proportionate share of total credit (Part 2, Line 4) and, if certified, the refundable portion (Part 3, Line 6). | Partner receives Form 308-P. |
| 4. Claiming | Partnership includes Form 308 and copies of 308-P with its return. | Partner uses 308-P amounts to claim credit on their return (e.g., Form 308-I or Form 308).10 |
Case Study: Illustrating Form 308-P Execution
To illustrate the critical function of Form 308-P, consider a partnership, R&D Innovators LLC, operating in Arizona.
A. Scenario Setup: R&D Innovators LLC (FYE 12/31/2024)
R&D Innovators LLC has determined its Arizona QREs for the year are substantial. Through the calculation on Form 308, the LLC determined its excess research expenditures are $\$4,000,000$.
- Total Calculated R&D Credit (Form 308, Line 29): $\$825,000$.
- Calculation Detail (Tiered Rate): The credit is calculated as 24% of the first $\$2.5$ million in excess QREs, plus 15% of the remaining $\$1.5$ million (4,000,000 – 2,500,000).14
- $(0.24 \times \$ 2,500,000) + (0.15 \times \$ 1,500,000) = \$ 600,000 + \$ 225,000 = \$ 825,000$.
- ACA Certification: The LLC successfully qualified and secured the ACA Certificate.
- Maximum Refund Amount (Form 308, Part 5, Line 35): $\$ 200,000$ (based on the authorized amount).
B. Partner Allocation Detail
R&D Innovators LLC has two main partners: Partner X (an individual) and Partner Y (a corporate entity), with profit and credit allocations set at 60% and 40%, respectively.
Table: Partnership R&D Credit Allocation Summary (Form 308-P Inputs)
| Partner | Proportionate Share (Line 2c) | Total Credit Allocation (Part 2, Line 4) | Refundable Portion Allocation (Part 3, Line 6) | Partner Type |
| Partner X | 60% | $495,000 | $120,000 | Individual |
| Partner Y | 40% | $330,000 | $80,000 | Corporate |
| Total | 100% | $825,000 | $200,000 |
C. Execution of Form 308-P for Partner X
The partnership completes Form 308-P specifically for Partner X to document their allocated share:
- Part 1 Completion: The partnership enters R&D Innovators LLC’s name and EIN. It enters Partner X’s name, SSN, and 60% proportionate share on Line 2.
- Part 2 (Total Credit): The total calculated credit of $\$825,000$ is entered on Line 3. Line 4 is calculated as $60\% \times \$ 825,000$, resulting in a total distributable credit of $\$ 495,000$ for Partner X.3
- Part 3 (Refundable Portion): The partnership confirms “Yes” for the ACA certificate. The maximum authorized refund of $\$ 200,000$ is entered on Line 5. Line 6 is calculated as $60\% \times \$ 200,000$, resulting in Partner X’s share of the refundable amount: $\$ 120,000$.10
Partner X, upon receipt of this completed Form 308-P, will claim the total $\$ 495,000$ credit on their Arizona Form 308-I. They may elect to receive up to the allocated refundable amount of $\$ 120,000$ as a cash refund (75% of the excess credit, as allowed by statute) or use the full credit against their income tax liability. Any non-refundable balance remaining must be carried forward for ten years, assuming the credit was established after December 31, 2021.2
This allocation illustrates the financial magnitude of the state R&D program. Utilizing the aggressive tiered rate structure, especially the 24% rate on the first $\$2.5$ million in excess QREs, generates a massive tax benefit at the entity level.14 For Partner X, the distribution of nearly half a million dollars in credits represents a substantial capital advantage, underscoring why meticulous compliance with Form 308-P is critical for effective partnership tax planning.
Conclusion and Strategic Takeaways
Form 308-P is an indispensable compliance mechanism for partnerships seeking to utilize the Arizona R&D tax credit. It is the mandatory schedule that translates the entity-level calculation into proportionate, legally recognized tax benefits for individual and corporate partners.1
The analysis of the Arizona R&D tax credit highlights two strategic compliance imperatives for flow-through entities. First, partnerships must manage the complex dual compliance requirements imposed by the ADOR (non-refundable calculation and carryover tracking) and the ACA (prerequisite for refundability).4 Proactive application for the ACA Certificate of Qualification is essential, given the competitive nature of the capped refundable fund pool.12 Second, given that the distribution on Form 308-P is purely mechanical, reflecting the underlying calculation on Form 308, the central point of audit defense must be established at the partnership level. Mitigating audit risk requires maintaining rigorous, contemporaneous documentation of QREs, as failure in the underlying calculation—due to gaps like missing technical narratives or improper wage allocation—will result in immediate, cascading adjustments to every partner’s allocated credit, regardless of their individual tax position.18
Finally, the shift in statutory carryforward periods (from 15 years to 10 years for new credits) necessitates updated strategic modeling for long-term credit utilization.2 This structural change increases the urgency for partners with limited near-term tax liability to pursue the refundable portion of the credit via the ACA application process.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
